Xbiome

Visit Tool

Xbiome is a Pharma & Biotech tool that develops AI-driven microbiome therapies. It combines AI with gut microbiome technology to accelerate drug development and offer solutions for intestinal and systemic diseases.

Claim this tool

1View

At a glance

Pricing

Likely Not Free

Free tier

API

Skill level

Technical

About

What is Xbiome?

Xbiome, also known as 未知君, is a leading AI microbiome research and industrial transformation platform in China. The company focuses on developing micro-ecological treatments, including formulated bacteria and genetically engineered microorganisms, to alleviate or treat intestinal and other systemic diseases. By integrating artificial intelligence with gut microbiome technology, Xbiome enhances data analysis, accumulation, and output, significantly improving the efficiency and success rate of drug development. Additionally, Xbiome researches and develops fecal microbiota transplantation solutions, probiotic products, and industry solutions, moving micro-ecology from scientific exploration to industrial application.

Best used for

Ideal for doctors, data scientists, and startup founders who need to develop advanced microbiome-based therapies, accelerate drug discovery processes, and translate complex scientific research into practical applications. Especially valuable for those focused on gut health and systemic disease treatment through innovative biotechnological approaches.

Common actions

develop microbiome therapies

accelerate drug discovery

analyze microbiome data

research gut health

Capabilities

Key features

AI microbiome research
Micro-ecological treatments
Drug development acceleration
Probiotic product development
Fecal microbiota transplantation

Target Audience

doctordata scientiststartup founder

Integrations

Not yet documented

Pricing & Plans

Likely Not Free

Not publicly disclosed. Check xbiome.com for current pricing.

FAQs

Does Xbiome offer its AI microbiome research platform as a service to external pharmaceutical companies or research institutions?

Xbiome primarily focuses on internal drug development and industrial applications. While they develop industry solutions, direct platform access for external entities is not explicitly stated. Potential collaborations would likely be on a partnership basis rather than a service model.

What types of diseases are Xbiome's micro-ecological treatments currently targeting or researching?

Xbiome's treatments are aimed at alleviating or treating intestinal and other systemic diseases. Specific disease targets are not detailed, but their focus on gut microbiome technology suggests conditions related to gut health and its systemic impacts.

How does Xbiome's AI integration specifically accelerate drug development compared to traditional methods?

Xbiome's AI enhances data analysis, accumulation, and output in microbiome research. This allows for more efficient identification of therapeutic targets, optimization of microbial formulations, and prediction of treatment efficacy, thereby improving the success rate and speed of drug development.

Trending

Subcategories trending in Wellness & Lifestyle

Clinical & Healthcare Pro Health & Fitness Gaming & Entertainment Mental Wellness Self-Improvement Medical & Symptom Checking

Trending

Explore

Browse AI tools by category

Content & Design Productivity & Business Coding & Development AI Agents & Automation Research & Education Wellness & Lifestyle Career Development Marketing & Growth Data & Analytics Customer Support & CX Finance E-commerce